SUZAN STEIN: Open Payments
NPI 1396173019 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 26 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $140 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $192 |
| Janssen Biotech, Inc. | 5 | $80 |
| Calyxo, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $45 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| UROGEN PHARMA, INC. | 1 | $15 |
| Boston Scientific Corporation | 1 | $15 |
Products named: GEMTESA, ERLEADA, CVAC ASPIRATION SYSTEM, XTANDI, ORGOVYX, KEYTRUDA, ZUSDURI, AMS 700.
Industry payments across PA — which companies pay providers there.
